THC
TENET HEALTHCARE CORP
NYSE · Healthcare · Medical - Care Facilities · US
$290.61
+8.97%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 22.8B | 21.3B | 20.7B | 20.5B | 19.2B |
| Cost of Revenue | 16.1B | 3.8B | 12.5B | 12.7B | 12.1B |
| Gross Profit | 6.7B | 17.5B | 8.2B | 7.8B | 7.0B |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 6.6B | 8.7B | 8.8B | 418.0M | 412.0M |
| General & Admin Expense | 2.2B | 8.7B | 8.8B | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (4.4B) | 5.4B | (6.5B) | 4.9B | 4.3B |
| Total Operating Expenses | 2.2B | 14.1B | 2.3B | 5.3B | 4.7B |
| Cost and Expenses | 18.3B | 17.9B | 14.7B | 18.0B | 16.8B |
| Operating Income (EBIT) | 4.5B | 3.4B | 6.0B | 2.5B | 2.3B |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | 817.0M | 821.0M | 826.0M | 901.0M | 890.0M |
| Net Interest Income | (817.0M) | (821.0M) | (826.0M) | (901.0M) | (890.0M) |
| Other Non-Op Income/Expense | 207.0M | (639.0M) | (708.0M) | (893.0M) | (988.0M) |
| Non-Operating Income (excl Interest) | (504.0M) | (182.0M) | (118.0M) | (8.0M) | 98.0M |
| EBT (Pre-Tax Income) | 4.7B | 2.8B | 5.2B | 1.6B | 1.3B |
| Income Tax Expense | 918.0M | 433.0M | 1.2B | 306.0M | 344.0M |
| Bottom Line | |||||
| Net Income | 2.9B | 1.4B | 3.2B | 611.0M | 411.0M |
| Earnings from Cont. Ops | 3.8B | 2.4B | 4.1B | 1.3B | 1.0B |
| Earnings from Discont. Ops | — | — | — | — | 1.0M |
| Bottom Line Net Income | 2.9B | 1.4B | 3.2B | 598.0M | 418.0M |
| Per Share | |||||
| Basic EPS | $34.71 | $15.61 | $33.02 | $6.01 | $3.84 |
| Diluted EPS | $34.48 | $15.49 | $32.70 | $5.71 | $3.79 |
| Revenue Per Share | $284.52 | $236.38 | $213.25 | $202.17 | $179.32 |
| Shares | |||||
| Basic Shares Outstanding | 80.1M | 90.2M | 96.9M | 101.6M | 106.9M |
| Diluted Shares Outstanding | 80.6M | 90.8M | 97.9M | 104.8M | 110.5M |
| Profitability Metrics | |||||
| EBITDA | 5.9B | 4.5B | 6.9B | 3.4B | 3.1B |
| D&A | 892.0M | 863.0M | 818.0M | 870.0M | 841.0M |
| EBIT | 5.0B | 3.6B | 6.1B | 2.5B | 2.2B |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026